1 Retroactively restated to give effect to the October 19, 2021 reverse recapitalization.
| SUPPLEMENTAL INFORMATION: | ||||||||||||||||
|
Three Months Ended
| Year Ended | |||||||||||||||
| December 31, | December 31, | |||||||||||||||
| 2021 | 2020 | 2021 | 2020 | |||||||||||||
| Stock-based compensation expenses included in: | ||||||||||||||||
| Net revenues | $ | — | $ | 331 | $ | 163 | $ | 331 | ||||||||
| Research and development | 4,926 | 302 | 6,624 | 477 | ||||||||||||
| Selling, general and administrative | 21,713 | 182 | 34,617 | 228 | ||||||||||||
| Total stock-based compensation expense | $ | 26,639 | $ | 815 | $ | 41,404 | $ | 1,036 | ||||||||
| Research and development includes: | ||||||||||||||||
| Amortization of acquisition-related intangible assets | $ | 87 | $ | 83 | $ | 361 | $ | 167 | ||||||||
| Other acquisition-related expenses included in: | ||||||||||||||||
| Research and development | $ | 500 | $ | — | $ | 500 | $ | — | ||||||||
| Selling, general and administrative | 1,795 | — | 1,795 | — | ||||||||||||
| Total other acquisition-related expenses | $ | 2,295 | $ | — | $ | 2,295 | $ | — | ||||||||
